Direxion Daily S&P Biotech Bull 3X ETF
LABU
33 hedge funds and large institutions have $42.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 8 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 3
58% more capital invested
Capital invested by funds: $26.8M → $42.4M (+$15.6M)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
14% more funds holding
Funds holding: 29 → 33 (+4)
6.26% more ownership
Funds ownership: 4.35% → 10.62% (+6.3%)
4% less call options, than puts
Call options by funds: $85.7M | Put options by funds: $89.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.3M |
| 2 |
CG
Cutler Group
San Francisco,
California
|
+$5.38M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.19M |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$3.05M |
| 5 |
RCM
Requisite Capital Management
Dallas,
Texas
|
+$2.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$7.14M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$1.98M |
| 3 |
XSC
X-Square Capital
Guaynabo,
Puerto Rico
|
-$414K |
| 4 |
MIC
Means Investment Company
Bangor,
Maine
|
-$288K |
| 5 |
VF
Virtu Financial
New York
|
-$271K |
LABU Hedge Fund Activity: Q4 2021 in Review
33 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2021, worth a combined $42.4M — up 58% from $26.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LABU positions and 8 closed out — a net gain of 4 holders — while 15 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $14.3M. The largest seller was HRT Financial, exiting entirely with an estimated $7.14M sold.
- 33 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2021, up from 29 in Q3 2021.
- Funds reported $42.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2021, up 58% quarter-over-quarter.
- 12 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2021 and 8 closed out, a net change of +4 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2021 was Citadel Advisors, an estimated $14.3M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2021 was HRT Financial, an estimated $7.14M sold.
Based on aggregated 13F filings for Q4 2021.